|
|
|
|
| LEADER |
03316nam a2200805 4500 |
| 001 |
ocn910720322 |
| 003 |
OCoLC |
| 005 |
20170124072119.8 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
130206s2013 enk sb 001 0 eng |
| 010 |
|
|
|a 2013005181
|
| 040 |
|
|
|a DLC
|b eng
|c DLC
|d MHW
|d N$T
|d YDXCP
|d DG1
|d CUI
|d STF
|d OCLCF
|d NLGGC
|d VLB
|d EBLCP
|d OCLCQ
|d DEBBG
|d D6H
|d GrThAP
|
| 019 |
|
|
|a 827010652
|
| 020 |
|
|
|a 9781118312056 ( ePub)
|
| 020 |
|
|
|a 1118312058 ( ePub)
|
| 020 |
|
|
|a 9781118312063 (MobiPocket)
|
| 020 |
|
|
|a 1118312066 (MobiPocket)
|
| 020 |
|
|
|a 9781118312131 (Adobe PDF)
|
| 020 |
|
|
|a 1118312139 (Adobe PDF)
|
| 020 |
|
|
|z 9781118312155 (cloth)
|
| 020 |
|
|
|a 9781118312087
|
| 020 |
|
|
|a 1118312082
|
| 029 |
1 |
|
|a NZ1
|b 15341511
|
| 029 |
1 |
|
|a DKDLA
|b 820120-katalog:000664376
|
| 029 |
1 |
|
|a DEBBG
|b BV042795505
|
| 029 |
1 |
|
|a GBVCP
|b 790209187
|
| 029 |
1 |
|
|a DEBBG
|b BV043397857
|
| 035 |
|
|
|a (OCoLC)910720322
|z (OCoLC)827010652
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RJ560
|
| 060 |
1 |
0 |
|a QV 771
|
| 072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 615/.190083
|2 23
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a Pediatric drug development
|h [electronic resource] :
|b concepts and applications /
|c [edited by] Andrew E. Mulberg, Dianne Murphy, Julia Dunne, Lisa L. Mathis.
|
| 250 |
|
|
|a Second edition.
|
| 264 |
|
1 |
|a Chichester, West Sussex, UK :
|b Wiley Blackwell,
|c 2013.
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a computer
|2 rdamedia
|
| 338 |
|
|
|a online resource
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record and CIP data provided by publisher.
|
| 520 |
|
|
|a Pediatric Drug Development, Second Edition, encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and other novel aspects of pediatric drug development.
|
| 650 |
|
0 |
|a Pediatric pharmacology.
|
| 650 |
|
0 |
|a Drug development.
|
| 650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
| 650 |
|
7 |
|a Drug development.
|2 fast
|0 (OCoLC)fst00898670
|
| 650 |
|
7 |
|a Pediatric pharmacology.
|2 fast
|0 (OCoLC)fst01056473
|
| 650 |
|
2 |
|a Child.
|
| 650 |
|
2 |
|a Drug Evaluation
|x methods.
|
| 650 |
|
2 |
|a Age Factors.
|
| 650 |
|
2 |
|a Clinical Trials as Topic
|x standards.
|
| 650 |
|
2 |
|a Drug Evaluation
|x ethics.
|
| 650 |
|
2 |
|a Drug Evaluation
|x standards.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Mulberg, Andrew E.,
|e editor of compilation.
|
| 700 |
1 |
|
|a Murphy, M. Dianne,
|e editor of compilation.
|
| 700 |
1 |
|
|a Dunne, Julia,
|d 1954-
|e editor of compilation.
|
| 700 |
1 |
|
|a Mathis, Lisa L.,
|e editor of compilation.
|
| 776 |
0 |
8 |
|i Print version:
|t Pediatric drug development
|b Second edition.
|d Chichester, West Sussex : John Wiley & Sons Inc., 2013
|z 9781118312155
|w (DLC) 2013004158
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781118312087
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
